|
AstraZeneca And Rigel Sign Worldwide License Agreement For A …
MarketWatch (press release) "Despite the number of medicines available to asthma patients today, there remains a need for more … in bringing innovative treatments for respiratory diseases to millions of patients around the world. … What eclipsing 50-day average means … AstraZeneca, Rigel to Develop Asthma Treatment |
View full post on world asthma day – Google News
